Thursday, June 13, 2013: Finally! A ruling in Association for Molecular Pathology v. Myriad Genetics, Inc. et al. Biotechnology company Myriad Genetics claimed exclusive rights to patents for ovarian and breast cancer DNA that it had isolated and genetically altered. However,… Read More ›
Image: Courtesy of the Centers for Disease Control and Prevention/Debora Cartagena The National Health Information Center has released its list of 2013 National Health Observances. Overall wellness is emphasized, and information regarding a number of diseases and medical syndromes may… Read More ›
MSP3 - The Policy Cafe 